Biomedical Engineering and Bioengineering Commons^™

Detection Of Antibodies Directed At M. Hyorhinis P37 In The Serum Of Men With Newly Diagnosed Prostate Cancer, Cydney Urbanek, Steve Goodison, Myron Chang, Stacy Porvasnik, Noburo Sakamoto, Chen-Zhong Li, Susan K. Boehlein, Charles J. Rosser

Department of Biomedical Engineering Faculty Publications

Background: Recent epidemiologic, genetic, and molecular studies suggest infection and inflammation initiate certain cancers, including cancers of the prostate. Over the past several years, our group has been studying how mycoplasmas could possibly initiate and propagate cancers of the prostate. Specifically, Mycoplasma hyorhinis encoded protein p37 was found to promote invasion of prostate cancer cells and cause changes in growth, morphology and gene expression of these cells to a more aggressive phenotype. Moreover, we found that chronic exposure of benign human prostate cells to M. hyorhinis resulted in significant phenotypic and karyotypic changes that ultimately resulted in the malignant transformation …

Biological Effective Dose (Bed) Distribution Matching For Obtaining Brachytherapy Prescription Doses & Dosimetric Optimization For Hybrid Seed Brachytherapy, Jakub Pritz

USF Tampa Graduate Theses and Dissertations

Radioactive seed implant brachytherapy is a common radiotherapy treatment method for prostate cancer. In current clinical practice, a seed consists of a single isotope, such as ¹²⁵I or ¹⁰³Pd. A seed containing a mixture of two isotopes has been proposed for prostate cancer treatment. This study investigates a method for defining a prescription dose for new seed compositions based on matching the biological equivalent dose (BED) of a reference plan.

Ten prostate cancer cases previously treated using single isotope seeds (5 using ¹²⁵I seeds and 5 using ¹⁰³Pd seeds) were selected for this study. Verification of …